Immune Therapeutics Issues Special Letter to Shareholders
January 30, 2017 08:40 ET
|
Immune Therapeutics, Inc.
Company Expects to Report Initial Revenues in First Half of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla.,...
Trxade Group, Inc. Appoints Independent Director
August 24, 2016 09:30 ET
|
Trxade Group, Inc.
TAMPA, Fla., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (OTCQB:TRXD), a web-based market platform with 6,200 registered independent pharmacy customers that enables its customers to...
Immune Therapeutics Receives NAFDAC Approval for Lodonal(TM) in Nigeria: Approval Follows Successful Recent Bridging Study
April 27, 2016 10:19 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., April 27, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN) (the “Company”), a clinical-stage biotech company providing immunotherapy solutions for the treatment...
CORRECTING and REPLACING -- Trxade Group Achieves Record First Quarter 2016 Financial Results Driven by a 165% Increase in Revenues Over First Quarter 2015
April 21, 2016 15:09 ET
|
Trxade Group, Inc.
TAMPA, Fla., April 21, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Trxade Group, Inc. (OTCQB: TRXD) we are advised by the company that the third bullet...
Trxade Group Achieves Record First Quarter 2016 Financial Results Driven by a 165% Increase in Revenues Over First Quarter 2015
April 21, 2016 09:15 ET
|
Trxade Group, Inc.
First Quarter Highlights:Company achieves record revenues of $1.8 million in quarter ending March 31, 2016, an increase of 165% over $696,000 in quarter ending March 31, 2015Gross profit increased to...
UPDATE -- Trxade Group, Inc. Launches HCTZ (Hydrochlorothiazide) to Treat Fluid Edema
February 09, 2016 14:04 ET
|
Trxade Group, Inc.
TAMPA, Fla., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (OTCQB:TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large...
Trxade Group, Inc. Launches HCTZ (Hydrochlorothiazide) to Treat Fluid Edema
February 09, 2016 10:15 ET
|
Trxade Group, Inc.
TAMPA, Fla., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (OTCQB:TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large...